StoneX Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $562K | Sell |
12,138
-4,377
| -27% | -$203K | 0.03% | 461 |
|
2025
Q1 | $1.01M | Buy |
16,515
+1,646
| +11% | +$100K | 0.06% | 287 |
|
2024
Q4 | $841K | Buy |
+14,869
| New | +$841K | 0.05% | 324 |
|
2022
Q2 | – | Sell |
-13,127
| Closed | -$965K | – | 545 |
|
2022
Q1 | $965K | Sell |
13,127
-3,307
| -20% | -$243K | 0.09% | 193 |
|
2021
Q4 | $1.02M | Sell |
16,434
-3,092
| -16% | -$193K | 0.12% | 165 |
|
2021
Q3 | $1.17M | Buy |
19,526
+1,052
| +6% | +$62.8K | 0.17% | 136 |
|
2021
Q2 | $1.23M | Buy |
18,474
+1,090
| +6% | +$72.8K | 0.18% | 118 |
|
2021
Q1 | $1.11M | Buy |
17,384
+562
| +3% | +$35.8K | 0.2% | 98 |
|
2020
Q4 | $1.05M | Buy |
16,822
+114
| +0.7% | +$7.13K | 0.23% | 87 |
|
2020
Q3 | $1.01M | Buy |
16,708
+779
| +5% | +$47K | 0.32% | 68 |
|
2020
Q2 | $937K | Sell |
15,929
-32
| -0.2% | -$1.88K | 0.36% | 69 |
|
2020
Q1 | $890K | Sell |
15,961
-7,127
| -31% | -$397K | 0.47% | 56 |
|
2019
Q4 | $1.48M | Buy |
+23,088
| New | +$1.48M | 0.6% | 43 |
|
2017
Q3 | – | Sell |
-6,928
| Closed | -$386K | – | 195 |
|
2017
Q2 | $386K | Buy |
+6,928
| New | +$386K | 0.12% | 233 |
|